| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/04/2010 | US20100029589 4,5-dihydro-oxazol-2yl derivatives |
| 02/04/2010 | US20100029586 Packaging for a Fabric softening Composition |
| 02/04/2010 | US20100029585 Toll-like receptor agonist formulations and their use |
| 02/04/2010 | US20100029584 Process for producing a cellulose-based film to be used for skin and tissue lesions |
| 02/04/2010 | US20100029582 Anticoagulant Antithrombotic Dual Inhibitors Comprising a Biotin Label |
| 02/04/2010 | US20100029581 Nutritional supplement |
| 02/04/2010 | US20100029580 Method for Diagnosing Non-Small Cell Lung Carcinoma |
| 02/04/2010 | US20100029579 Antiviral compounds |
| 02/04/2010 | US20100029578 Methods of Treating Atrial Fibrillation with P38 Inhibitor Compounds |
| 02/04/2010 | US20100029577 Chiral separation, characterization and biological action of optically active isomers of digoxin |
| 02/04/2010 | US20100029576 Diazoxide for the treatment of Friedreich's Ataxia |
| 02/04/2010 | US20100029567 Method of correcting imbalance between bone resorption and bone formation and kits and compositions therefor |
| 02/04/2010 | US20100029560 Compositions and methods for diagnosing, treating, and preventing prostate conditions |
| 02/04/2010 | US20100029552 Peptide inhibitors of c-jun dimerization and uses thereof |
| 02/04/2010 | US20100029551 Treatment Of Inflammatory Lung Conditions With Aerosolized Macrolide Antibiotics |
| 02/04/2010 | US20100029544 Composition |
| 02/04/2010 | US20100029484 Oxabicycloheptanes and oxabicycloheptenes, their preparation and use |
| 02/04/2010 | US20100028970 Medium for the Production of Tiacumicin B |
| 02/04/2010 | US20100028936 Detection of cancer cells in vitro using sigma-2 receptor ligands as radiotracers |
| 02/04/2010 | US20100028905 Characterization of grp94-ligand interactions and purification, screening, and therapeutic methods relating thereto |
| 02/04/2010 | US20100028823 Anti-microbial orthodontic compositions and appliances and methods of production and use thereof |
| 02/04/2010 | US20100028473 Body fat-reducing agent |
| 02/04/2010 | US20100028469 Extracts of Cranberry and Methods of Using Thereof |
| 02/04/2010 | US20100028468 Formulations containing thymoquinone for urinary health |
| 02/04/2010 | US20100028467 Composition Comprising Ginsenosides Isolated From The Extract Of Processed Ginseng For Preventing And Treating Thrombotic Disease |
| 02/04/2010 | US20100028465 Composition for ameliorating cerebral function |
| 02/04/2010 | US20100028464 Use of saffron and/or safranal and/or crocin and/or picrocrocin and/or derivatives thereof as a sateity agent for treatment of obesity |
| 02/04/2010 | US20100028461 Gamma-butyrolactone compound and pharmaceutical composition thereof |
| 02/04/2010 | US20100028460 Improvements in relation to cancer therapy |
| 02/04/2010 | US20100028451 Silk microspheres for encapsulation and controlled release |
| 02/04/2010 | US20100028447 Intranasal, Buccal, And Sublingual Administration Of Metanicotine Analogs |
| 02/04/2010 | US20100028445 Polymer |
| 02/04/2010 | US20100028444 Use of water-dispersible carotenoid nanoparticles as taste modulators, taste modulators containing water-dispersible carotenoid nanoparticles, and, method for taste modulation |
| 02/04/2010 | US20100028442 Methods of therapeutic treatment of eyes |
| 02/04/2010 | US20100028440 Drying of drug-containing particles |
| 02/04/2010 | US20100028439 Nanoparticulate stabilized anti-hypertensive compositions |
| 02/04/2010 | US20100028438 Hyaluronic Acid-Based Gels Including Lidocaine |
| 02/04/2010 | US20100028437 Hyaluronic Acid-Based Gels Including Lidocaine |
| 02/04/2010 | US20100028435 Injectable hydrogel with an enhanced remanence and with an enhanced ability to create volume |
| 02/04/2010 | US20100028432 Formulations of active principles incorporated in slns suitable for transdermal administration |
| 02/04/2010 | US20100028431 Compositions and methods for therapeutic use |
| 02/04/2010 | US20100028429 Salts of potassium atp channel openers and uses thereof |
| 02/04/2010 | US20100028428 Fumarate salt of (alpha s, beta r)-6-bromo-alpha-[2-(dimethylamino)ethyl]-2-methoxy-alpha-1-naphthalenyl-beta-phenyl-3-quinolineethanol |
| 02/04/2010 | US20100028427 Immediate release formulations of 1-aminocyclohexane compounds, memantine and neramexane |
| 02/04/2010 | US20100028426 Time-specific delayed/pulsatile release dosage forms. |
| 02/04/2010 | US20100028425 Pharmaceutical composition of atovaquone |
| 02/04/2010 | US20100028421 Solid Oral Dosage Form Containing an Enhancer |
| 02/04/2010 | US20100028417 Use of substituted glycerin derivatives for producing a pharmaceutical preparation |
| 02/04/2010 | US20100028416 Drug carriers |
| 02/04/2010 | US20100028414 Combination of tyrosine kinase inhibitor and her-2/neu for cancer therapy |
| 02/04/2010 | US20100028406 Topical drug delivery by iontophoresis |
| 02/04/2010 | US20100028402 Nanoparticle-based anticoagulant |
| 02/04/2010 | US20100028401 Stem cell source for promoting neovascularisation |
| 02/04/2010 | US20100028400 Pharmaceutical composition on the basis of stachytarpheta sp., a process for obtaining the same and its use for treating vitiligo |
| 02/04/2010 | US20100028396 Tissue scaffolds derived from forestomach extracellular matrix |
| 02/04/2010 | US20100028389 Controlled release dosage form for pain relief; continuously release-rate controlled doses |
| 02/04/2010 | US20100028374 C-type lectin transmembrane antigen expressed in human prostate cancer and uses therof |
| 02/04/2010 | US20100028368 Sulfide, sulfoxide and sulfone chalcone analogues, derivatives thereof and therapeutic uses thereof |
| 02/04/2010 | US20100028365 Methods and compositions for the diagnosis and treatment of cancer |
| 02/04/2010 | US20100028364 Inhibition of sox9 function in the treatment of proteoglycan-associated pathophysiological conditions |
| 02/04/2010 | US20100028361 Brain-derived gonadotropins and cognition |
| 02/04/2010 | US20100028360 Methods for the modulation of brain progestagen signaling in the prevention and treatment of neurological disorders and neurodegenerative diseases |
| 02/04/2010 | US20100028355 Himf and btk in pulmonary, cardiac and inflammation disorders |
| 02/04/2010 | US20100028353 Anti-amyloid immunogenic compositions, methods and uses |
| 02/04/2010 | US20100028352 COMPOSITIONS AND METHODS COMPRISING GLYCYL-tRNA SYNTHETASES HAVING NON-CANONICAL BIOLOGICAL ACTIVITIES |
| 02/04/2010 | US20100028350 Preventing il-2 mediated inflammation in epithelial cells |
| 02/04/2010 | US20100028348 Compositions and Methods for Inhibiting an Isoform of Human Manganese Superoxide Dismutase |
| 02/04/2010 | US20100028346 Novel synergistic effects |
| 02/04/2010 | US20100028344 Conditioned cell immunization |
| 02/04/2010 | US20100028338 Gimatecan (7-t-butoxyiminomethylcamptothecin) and chemotherapeutic agents |
| 02/04/2010 | US20100028337 Methods and compositions for modulating hyperstabilized c-met |
| 02/04/2010 | US20100028327 Novel low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis |
| 02/04/2010 | US20100028326 Diagnosis of hyperinsulinemia and type ii diabetes and protection against same based on proteins differentially expressed in serum |
| 02/04/2010 | US20100028318 Agent for relief or prevention of xerostomia |
| 02/04/2010 | US20100028317 Skin Repair Compositions Comprising Circadian Gene Activators And A Synergistic Combination Of Sirt1 Gene Activators |
| 02/04/2010 | US20100028302 Use of IGFBP-2 in Senescence Diseases and for the Maintenance of Organ Functions |
| 02/04/2010 | US20100028301 IMIDAZO[4,5-c]PYRIDINE COMPOUNDS AND METHODS OF ANTIVIRAL TREATMENT |
| 02/04/2010 | US20100028299 Methods and compositions of treating a flaviviridae family viral infection |
| 02/04/2010 | US20100028292 Amphiphilic Polymer-Protein Conjugates and Methods of Use Thereof |
| 02/04/2010 | US20100028291 Microbicidal and antiseptic gel composition |
| 02/04/2010 | US20100028290 Disinfectant |
| 02/04/2010 | US20100028278 Use of chroman-4-one derivatives |
| 02/04/2010 | US20100028277 Composition containing a compound capable of establishing hydrogen bonds, and cosmetic treatment process |
| 02/04/2010 | US20100028275 Alkyl Benzoate Mixtures |
| 02/04/2010 | US20100028270 Urethane compound comprising an incorporated polyether group-containing silicone derivative and a nitrogen heterocycle |
| 02/04/2010 | US20100028267 Compositions and methods for reducing capillary permeability |
| 02/04/2010 | US20100028266 Composition and methods for treating allergic response |
| 02/04/2010 | US20100028262 3,4-methylenedioxy-substituted chalcones as therapeutic agents |
| 02/04/2010 | US20100028257 Pharmaceutical compounds |
| 02/04/2010 | US20100026235 Charging Control in an Electric Vehicle |
| 02/04/2010 | DE20321786U1 Kombinationspräparat aus oralem Kontrazeptivum und Calcium/Vitamin D Combination preparation of oral contraceptive and calcium / vitamin D |
| 02/04/2010 | DE10328003B4 Mittel gegen einzellige Parasiten von Fischen Agents against protozoan parasites of fish |
| 02/04/2010 | DE102008035596A1 Derivate benzoannelierter Stickstoff-Heterocyclen Derivatives benzoannelierter nitrogen heterocycles |
| 02/04/2010 | DE102008035552A1 Substituierte Pyridine und ihre Verwendung Substituted pyridines and their use |
| 02/04/2010 | DE102008035209A1 New nitrogen substituted heterocyclic compounds are glycogen synthase kinase 3-beta inhibitors useful e.g. to treat and/or prevent hematological disease, preferably leukopenia, and for ex-vivo increase of adult hematopoietic stem cells |
| 02/04/2010 | CA2738510A1 6-substituted isoflavonoid compounds and uses thereof |
| 02/04/2010 | CA2733390A1 Methionine analogs and methods of using same |
| 02/04/2010 | CA2733077A1 Composition for prophylaxis or treatment of hyperlipidemia, fatty liver or obesity |
| 02/04/2010 | CA2733001A1 Of tetrakis (n-alkylpyridinium) -porphyrin derivatives for killing microbes or preventing growth |
| 02/04/2010 | CA2732864A1 A pharmaceutical composition for preventing or treating osteoporosis comprising benzamidine derivative or its salt, and bisphosphonate |